In times of a public health crisis, the cracks in the system that leave many patients vulnerable can become even more apparent. While our country continues to grapple with the uncertainty of the novel coronavirus (COVID-19) and its implications on our current healthcare system, patients with chronic illnesses are at a particular risk of declining health. Pharmaceutical companies, with the support of patient hubs, are well-positioned to identify patients who are most at risk of experiencing a disruption in their therapy. With the proper technology and capabilities in place, pharmaceutical companies can recognize potential barriers to care and address the needs of their patient populations through additional support and assistance offerings.
Rebecca Cotton, Executive Director, Data Analytics and Intelligence at Cardinal Health Sonexus™ Access & Patient Support recently contributed a perspective to PharmExec.com focused on this topic and potential solutions.
Read more by visiting PharmExec.com now »